Dark | Light
# Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences (NBIX) faces a stock dip due to missed EPS and a failed study, despite strong INGREZZA sales. Analysts remain cautiously optimistic with some lowering price targets.

### About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.  
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Neurocrine Biosciences, Inc. (NBIX) market dominance near a 52-week low at [-------].
- Neurocrine Biosciences, Inc. (NBIX) trading volume is up 66.03% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) Galaxy Score™ is up 112% from the previous month.
- Neurocrine Biosciences, Inc. (NBIX) sentiment is up 44.93% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) creators is up 55% from the previous week.
- Neurocrine Biosciences, Inc. (NBIX) engagements is up 116.04% from the previous month.
- Neurocrine Biosciences, Inc. (NBIX) mentions is up 97.11% from the previous week.
- Neurocrine Biosciences, Inc. entered the top [--] AltRank™ for the first time 

### Price: $128.40
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/close.tsv)  
The stock price experienced a minor dip of -1.92% in the last [--] hours, primarily due to missed EPS estimates and the failure of the KINECT-DCP study, despite strong INGREZZA sales and positive analyst sentiment.  

24-Hour: 0.49%
7-Day: -3.11%
30-Day: -4.58%

1-Year High: $155.60 on 2025-12-10  
1-Year Low: $87.50 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/alt_rank.tsv)  
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #399 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +816  
[--] Month: [-----] +396  
[--] Months: [-----] +346  
[--] Year: [-----] [----]  
1-Year High: [-----] on 2026-02-01  
1-Year Low: [--] on 2025-07-12  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +8  
[--] Month: [--] +28  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-07-02  
1-Year Low: [--] on 2025-09-24  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [-------] +41%  
[--] Month: [-------] +116%  
[--] Months: [---------] -57%  
[--] Year: [---------] -3.10%  
1-Year High: [-------] on 2025-05-05  
1-Year Low: [---] on 2026-02-01  

Engagements by network (24h):
News: [--]
Reddit: [--]
X: [-----]
TikTok: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] +97%  
[--] Month: [---] +19%  
[--] Months: [-----] -86%  
[--] Year: [------] +259%  
1-Year High: [-----] on 2025-07-03  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
News: [--]
Reddit: [--]
X: [--]
TikTok: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is down 14% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +55%  
[--] Month: [---] -9.20%  
[--] Months: [---] -93%  
[--] Year: [------] +701%  
1-Year High: [-----] on 2025-07-03  
1-Year Low: [--] on 2025-12-07  

The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours

| Creator                                                                | Rank | Followers  | Posts | Engagements |
| -------                                                                | ---- | ---------  | ----- | ----------- |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)                             | [--]    | [-----]      | [--]     | [---]         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)                       | [--]    | [-----]      | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)                       | [--]    | [-----]      | [--]     | [---]         |
| [@OracleEarnings](/creator/twitter/OracleEarnings)                     | [--]    | [------]     | [--]     | [---]         |
| [@AIStockSavvy](/creator/twitter/AIStockSavvy)                         | [--]    | [------]     | [--]     | [--]          |
| [@Pharmdca](/creator/twitter/Pharmdca)                                 | [--]    | [-------]    | [--]     | [--]          |
| [@moneyforfun_](/creator/twitter/moneyforfun_)                         | [--]    | [-----]      | [--]     | [--]          |
| [@OpenOutcrier](/creator/twitter/OpenOutcrier)                         | [--]    | [----------] | [--]     | [--]          |
| [@neurocrinebiosciencesinc](/creator/youtube/neurocrinebiosciencesinc) | [--]   | [--]         | [--]     | [--]           |

[View More](/list/creators/neurocrine-biosciences-inc/100)
  
  
### Sentiment: 85%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/sentiment.tsv)  
Current Value: 85%  
Daily Average: 67%  
[--] Week: 100% +31%  
[--] Month: 79% -4%  
[--] Months: 79% no change  
[--] Year: 79% +25%  
1-Year High: 100% on 2025-07-20  
1-Year Low: 25% on 2025-09-15  

Most Supportive Themes:
- Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
- Crenessity Phase [--] Study: (35%) Positive outcomes from the Crenessity Phase [--] study boost confidence in Neurocrine's pipeline.
- Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.
  
Most Critical Themes:
- Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.
  
  
  
### Social Dominance: 0.00455%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/social_dominance.tsv)  
Current Value: 0.00455%  
Daily Average: 0.02%  
[--] Week: 0.00407% -0.018%  
[--] Month: 0.0066% +0.002%  
[--] Months: 0.0066% -0.014%  
[--] Year: 0.0066% -0.031%  
1-Year High: 0.211% on 2025-07-03  
1-Year Low: 0.0021% on 2025-12-07  
  
  
### Market Dominance: 0.015%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_dominance.tsv)  
Current Value: 0.015%  
Daily Average: 0%  
1-Year High: 0.389% on 2025-04-09  
1-Year Low: 0.014% on 2026-02-12  
  
  
### Market Cap: $12,884,661,380
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:neurocrine-biosciences-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_cap.tsv)  
Current Value: $12,884,661,380  
Daily Average: $13,021,887,182  
[--] Week: $12,884,661,380 -0.76%  
[--] Month: $12,884,661,380 -2.40%  
[--] Months: $12,884,661,380 -4.10%  
[--] Year: $12,884,661,380 +13%  
1-Year High: $15,517,197,780 on 2025-12-10  
1-Year Low: $8,990,517,324 on 2025-04-12  

### Top Neurocrine Biosciences, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$MU -Needham raises Micron target to $450 from $380 Buy - $NBIX -JPMorgan lowers Neurocrine Biosciences target to $176 from $177 Overweight -Truist lowers target to $140 from $169 Buy - $NMRA -William Blair upgrades Neumora Therapeutics to Outperform from Market Perform -"  
[X Link](https://x.com/MarcJacksonLA/status/2023970380017209579) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-18T03:58Z [----] followers, [---] engagements


"End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY"  
[X Link](https://x.com/Andre_AGTC/status/2006437257927078374) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-12-31T18:48Z [----] followers, 18K engagements


"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK"  
[X Link](https://x.com/Andre_AGTC/status/1973033636619555030) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-30T14:34Z [----] followers, 37.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences (NBIX) faces a stock dip due to missed EPS and a failed study, despite strong INGREZZA sales. Analysts remain cautiously optimistic with some lowering price targets.

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Neurocrine Biosciences, Inc. (NBIX) market dominance near a 52-week low at [-------].
  • Neurocrine Biosciences, Inc. (NBIX) trading volume is up 66.03% from the previous week.
  • Neurocrine Biosciences, Inc. (NBIX) Galaxy Score™ is up 112% from the previous month.
  • Neurocrine Biosciences, Inc. (NBIX) sentiment is up 44.93% from the previous week.
  • Neurocrine Biosciences, Inc. (NBIX) creators is up 55% from the previous week.
  • Neurocrine Biosciences, Inc. (NBIX) engagements is up 116.04% from the previous month.
  • Neurocrine Biosciences, Inc. (NBIX) mentions is up 97.11% from the previous week.
  • Neurocrine Biosciences, Inc. entered the top [--] AltRank™ for the first time

Price: $128.40

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price experienced a minor dip of -1.92% in the last [--] hours, primarily due to missed EPS estimates and the failure of the KINECT-DCP study, despite strong INGREZZA sales and positive analyst sentiment.

24-Hour: 0.49% 7-Day: -3.11% 30-Day: -4.58%

1-Year High: $155.60 on 2025-12-10
1-Year Low: $87.50 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #399 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +816
[--] Month: [-----] +396
[--] Months: [-----] +346
[--] Year: [-----] [----]
1-Year High: [-----] on 2026-02-01
1-Year Low: [--] on 2025-07-12

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +8
[--] Month: [--] +28
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-07-02
1-Year Low: [--] on 2025-09-24

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-------] +41%
[--] Month: [-------] +116%
[--] Months: [---------] -57%
[--] Year: [---------] -3.10%
1-Year High: [-------] on 2025-05-05
1-Year Low: [---] on 2026-02-01

Engagements by network (24h): News: [--] Reddit: [--] X: [-----] TikTok: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] +97%
[--] Month: [---] +19%
[--] Months: [-----] -86%
[--] Year: [------] +259%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): News: [--] Reddit: [--] X: [--] TikTok: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is down 14% from [--] in the previous [--] hours Daily Average: [---]
[--] Week: [---] +55%
[--] Month: [---] -9.20%
[--] Months: [---] -93%
[--] Year: [------] +701%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07

The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours

Creator Rank Followers Posts Engagements
@Andre_AGTC [--] [-----] [--] [---]
@MarcJacksonLA [--] [-----] [--] [---]
@doepke_michel [--] [-----] [--] [---]
@OracleEarnings [--] [------] [--] [---]
@AIStockSavvy [--] [------] [--] [--]
@Pharmdca [--] [-------] [--] [--]
@moneyforfun_ [--] [-----] [--] [--]
@OpenOutcrier [--] [----------] [--] [--]
@neurocrinebiosciencesinc [--] [--] [--] [--]

View More

Sentiment: 85%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 85%
Daily Average: 67%
[--] Week: 100% +31%
[--] Month: 79% -4%
[--] Months: 79% no change
[--] Year: 79% +25%
1-Year High: 100% on 2025-07-20
1-Year Low: 25% on 2025-09-15

Most Supportive Themes:

  • Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue.
  • Crenessity Phase [--] Study: (35%) Positive outcomes from the Crenessity Phase [--] study boost confidence in Neurocrine's pipeline.
  • Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.

Most Critical Themes:

  • Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.

Social Dominance: 0.00455%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00455%
Daily Average: 0.02%
[--] Week: 0.00407% -0.018%
[--] Month: 0.0066% +0.002%
[--] Months: 0.0066% -0.014%
[--] Year: 0.0066% -0.031%
1-Year High: 0.211% on 2025-07-03
1-Year Low: 0.0021% on 2025-12-07

Market Dominance: 0.015%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.015%
Daily Average: 0%
1-Year High: 0.389% on 2025-04-09
1-Year Low: 0.014% on 2026-02-12

Market Cap: $12,884,661,380

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $12,884,661,380
Daily Average: $13,021,887,182
[--] Week: $12,884,661,380 -0.76%
[--] Month: $12,884,661,380 -2.40%
[--] Months: $12,884,661,380 -4.10%
[--] Year: $12,884,661,380 +13%
1-Year High: $15,517,197,780 on 2025-12-10
1-Year Low: $8,990,517,324 on 2025-04-12

Top Neurocrine Biosciences, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$MU -Needham raises Micron target to $450 from $380 Buy - $NBIX -JPMorgan lowers Neurocrine Biosciences target to $176 from $177 Overweight -Truist lowers target to $140 from $169 Buy - $NMRA -William Blair upgrades Neumora Therapeutics to Outperform from Market Perform -"
X Link @MarcJacksonLA 2026-02-18T03:58Z [----] followers, [---] engagements

"End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY"
X Link @Andre_AGTC 2025-12-31T18:48Z [----] followers, 18K engagements

"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK"
X Link @Andre_AGTC 2025-09-30T14:34Z [----] followers, 37.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Neurocrine Biosciences, Inc. (NBIX)
/topic/neurocrine-biosciences-inc